Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis

M. A. Viviani, A. M. Tortorano, C. Malaspina, M. Colledan, G. Paone, G. Rossi, G. Bordone, A. Pagano

Research output: Contribution to journalArticle

Abstract

Between June 1988 and May 1991 88 orthotopic liver transplants and 1 liver and pancreas transplant were performed at the Liver Transplantation Department of the Ospedale Maggiore of Milan. All the patients underwent mycological surveillance and received antifungal prophylaxis with oral amphotericin B (6000 mg/day) or oral or intravenous fluconazole (200 mg/day) from the time of their transplant. The incidence of Candida colonization was 67%. Fluconazole was superior to oral amphotericin B in the treatment of C. albicans colonization (99 vs 15), but less effective in the treatment of colonization by other Candida spp. (03 vs 33). Deep-seated candidiasis developed in 5 patients, caused by C. albicans in 4 cases and C. krusei in 1. C. albicans infection resolved rapidly with fluconazole in 2 subjects, with intravenous amphotericin B alone in 1, and with amphotericin B plus flucytosine in the other. On the contrary, C. krusei infection did not respond to treatment with amphotericin B combined with flucytosine. Aspergillosis was diagnosed in 11 patients, of whom 4 died from invasive aspergillosis, despite 15 and 26 days of amphotericin B treatment in 2. In another patient invasive aspergillosis, diagnosed a few hours before retransplantation, improved with liposomal amphotericin B, but this man died from cytomegalovirus infection one month later. Aspergillosis was eradicated by itraconazole in 4 other patients and by topical amphotericin B in 2 whose infection was localized to surgical wound.

Original languageEnglish
Pages (from-to)433-436
Number of pages4
JournalEuropean Journal of Epidemiology
Volume8
Issue number3
DOIs
Publication statusPublished - May 1992

Fingerprint

Aspergillosis
Candidiasis
Amphotericin B
Liver
Fluconazole
Flucytosine
Transplants
Candida
Therapeutics
Infection
Itraconazole
Cytomegalovirus Infections
Transplant Recipients
Liver Transplantation
Pancreas
Incidence

Keywords

  • Antifungal treatment
  • Liver transplant
  • Opportunistic fungal infections

ASJC Scopus subject areas

  • Epidemiology

Cite this

Viviani, M. A., Tortorano, A. M., Malaspina, C., Colledan, M., Paone, G., Rossi, G., ... Pagano, A. (1992). Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. European Journal of Epidemiology, 8(3), 433-436. https://doi.org/10.1007/BF00158579

Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. / Viviani, M. A.; Tortorano, A. M.; Malaspina, C.; Colledan, M.; Paone, G.; Rossi, G.; Bordone, G.; Pagano, A.

In: European Journal of Epidemiology, Vol. 8, No. 3, 05.1992, p. 433-436.

Research output: Contribution to journalArticle

Viviani, MA, Tortorano, AM, Malaspina, C, Colledan, M, Paone, G, Rossi, G, Bordone, G & Pagano, A 1992, 'Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis', European Journal of Epidemiology, vol. 8, no. 3, pp. 433-436. https://doi.org/10.1007/BF00158579
Viviani, M. A. ; Tortorano, A. M. ; Malaspina, C. ; Colledan, M. ; Paone, G. ; Rossi, G. ; Bordone, G. ; Pagano, A. / Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. In: European Journal of Epidemiology. 1992 ; Vol. 8, No. 3. pp. 433-436.
@article{15552d530f5a41768cf8a1450f84dbbc,
title = "Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis",
abstract = "Between June 1988 and May 1991 88 orthotopic liver transplants and 1 liver and pancreas transplant were performed at the Liver Transplantation Department of the Ospedale Maggiore of Milan. All the patients underwent mycological surveillance and received antifungal prophylaxis with oral amphotericin B (6000 mg/day) or oral or intravenous fluconazole (200 mg/day) from the time of their transplant. The incidence of Candida colonization was 67{\%}. Fluconazole was superior to oral amphotericin B in the treatment of C. albicans colonization (99 vs 15), but less effective in the treatment of colonization by other Candida spp. (03 vs 33). Deep-seated candidiasis developed in 5 patients, caused by C. albicans in 4 cases and C. krusei in 1. C. albicans infection resolved rapidly with fluconazole in 2 subjects, with intravenous amphotericin B alone in 1, and with amphotericin B plus flucytosine in the other. On the contrary, C. krusei infection did not respond to treatment with amphotericin B combined with flucytosine. Aspergillosis was diagnosed in 11 patients, of whom 4 died from invasive aspergillosis, despite 15 and 26 days of amphotericin B treatment in 2. In another patient invasive aspergillosis, diagnosed a few hours before retransplantation, improved with liposomal amphotericin B, but this man died from cytomegalovirus infection one month later. Aspergillosis was eradicated by itraconazole in 4 other patients and by topical amphotericin B in 2 whose infection was localized to surgical wound.",
keywords = "Antifungal treatment, Liver transplant, Opportunistic fungal infections",
author = "Viviani, {M. A.} and Tortorano, {A. M.} and C. Malaspina and M. Colledan and G. Paone and G. Rossi and G. Bordone and A. Pagano",
year = "1992",
month = "5",
doi = "10.1007/BF00158579",
language = "English",
volume = "8",
pages = "433--436",
journal = "European Journal of Epidemiology",
issn = "0393-2990",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis

AU - Viviani, M. A.

AU - Tortorano, A. M.

AU - Malaspina, C.

AU - Colledan, M.

AU - Paone, G.

AU - Rossi, G.

AU - Bordone, G.

AU - Pagano, A.

PY - 1992/5

Y1 - 1992/5

N2 - Between June 1988 and May 1991 88 orthotopic liver transplants and 1 liver and pancreas transplant were performed at the Liver Transplantation Department of the Ospedale Maggiore of Milan. All the patients underwent mycological surveillance and received antifungal prophylaxis with oral amphotericin B (6000 mg/day) or oral or intravenous fluconazole (200 mg/day) from the time of their transplant. The incidence of Candida colonization was 67%. Fluconazole was superior to oral amphotericin B in the treatment of C. albicans colonization (99 vs 15), but less effective in the treatment of colonization by other Candida spp. (03 vs 33). Deep-seated candidiasis developed in 5 patients, caused by C. albicans in 4 cases and C. krusei in 1. C. albicans infection resolved rapidly with fluconazole in 2 subjects, with intravenous amphotericin B alone in 1, and with amphotericin B plus flucytosine in the other. On the contrary, C. krusei infection did not respond to treatment with amphotericin B combined with flucytosine. Aspergillosis was diagnosed in 11 patients, of whom 4 died from invasive aspergillosis, despite 15 and 26 days of amphotericin B treatment in 2. In another patient invasive aspergillosis, diagnosed a few hours before retransplantation, improved with liposomal amphotericin B, but this man died from cytomegalovirus infection one month later. Aspergillosis was eradicated by itraconazole in 4 other patients and by topical amphotericin B in 2 whose infection was localized to surgical wound.

AB - Between June 1988 and May 1991 88 orthotopic liver transplants and 1 liver and pancreas transplant were performed at the Liver Transplantation Department of the Ospedale Maggiore of Milan. All the patients underwent mycological surveillance and received antifungal prophylaxis with oral amphotericin B (6000 mg/day) or oral or intravenous fluconazole (200 mg/day) from the time of their transplant. The incidence of Candida colonization was 67%. Fluconazole was superior to oral amphotericin B in the treatment of C. albicans colonization (99 vs 15), but less effective in the treatment of colonization by other Candida spp. (03 vs 33). Deep-seated candidiasis developed in 5 patients, caused by C. albicans in 4 cases and C. krusei in 1. C. albicans infection resolved rapidly with fluconazole in 2 subjects, with intravenous amphotericin B alone in 1, and with amphotericin B plus flucytosine in the other. On the contrary, C. krusei infection did not respond to treatment with amphotericin B combined with flucytosine. Aspergillosis was diagnosed in 11 patients, of whom 4 died from invasive aspergillosis, despite 15 and 26 days of amphotericin B treatment in 2. In another patient invasive aspergillosis, diagnosed a few hours before retransplantation, improved with liposomal amphotericin B, but this man died from cytomegalovirus infection one month later. Aspergillosis was eradicated by itraconazole in 4 other patients and by topical amphotericin B in 2 whose infection was localized to surgical wound.

KW - Antifungal treatment

KW - Liver transplant

KW - Opportunistic fungal infections

UR - http://www.scopus.com/inward/record.url?scp=0026786421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026786421&partnerID=8YFLogxK

U2 - 10.1007/BF00158579

DO - 10.1007/BF00158579

M3 - Article

C2 - 1397207

AN - SCOPUS:0026786421

VL - 8

SP - 433

EP - 436

JO - European Journal of Epidemiology

JF - European Journal of Epidemiology

SN - 0393-2990

IS - 3

ER -